Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub

FREE event with the FDA to use your voice and advocate!

The Reagan-Udall Foundation for the FDA, in collaboration with FDA’s Rare Disease Innovation Hub, will host a public meeting on October 16, 2024. The meeting will bring together rare disease patient advocates, academic researchers, regulated industry, and other key stakeholders to discuss how the recently announced Rare Disease Innovation Hub can best engage with members of the rare disease community and prioritize its work.

Herpes is not rare. But many of its serious health outcomes are. HSV Encephalitis. HSV Keratitis. Neonatal HSV. Use your voice and help us make a difference!

To learn more and register for FREE, click here!